We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$65.1B
AUM Growth
+$4.63B
Cap. Flow
+$746M
Cap. Flow %
1.15%
Top 10 Hldgs %
9.56%
Holding
3,794
New
469
Increased
1,367
Reduced
1,237
Closed
370

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$354M
2
WFC icon
Wells Fargo
WFC
+$274M
3
IBM icon
IBM
IBM
+$266M
4
QCOM icon
Qualcomm
QCOM
+$257M
5
MDLZ icon
Mondelez International
MDLZ
+$224M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$356M
2
PYPL icon
PayPal
PYPL
+$290M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$261M
4
NVDA icon
NVIDIA
NVDA
+$248M
5
AABA
Altaba Inc
AABA
+$245M

Sector Composition

Rank Sector Weight
1 Technology 14.31%
2 Healthcare 10.66%
3 Consumer Discretionary 10.29%
4 Communication Services 8.78%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMOS
2701
DELISTED
Lumos Networks Corp
LMOS
$679K ﹤0.01%
37,897
-1,100
-3% -$19.7K
HLF icon
2702
CALL
Herbalife
HLF
$1.34B
$678K ﹤0.01%
20,000
– –
IXYS
2703
DELISTED
IXYS Corp
IXYS
$678K ﹤0.01%
28,589
-63,283
-69% -$1.2M
BHBK
2704
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$677K ﹤0.01%
35,263
+4,102
+13% +$76.5K
RARE icon
2705
Ultragenyx Pharmaceutical
RARE
$2.6B
$675K ﹤0.01%
12,682
-54,193
-81% -$3.21M
TRV icon
2706
PUT
Travelers Companies
TRV
$76.9B
$674K ﹤0.01%
5,500
– –
WLK icon
2707
Westlake Corp
WLK
$9.57B
$673K ﹤0.01%
+8,098
New +$595K
BKR icon
2708
CALL
Baker Hughes
BKR
$61.9B
$670K ﹤0.01%
+18,300
New +$650K
CAKE icon
2709
PUT
Cheesecake Factory
CAKE
$5.65B
$670K ﹤0.01%
+15,900
New +$708K
ADAP
2710
DELISTED
Adaptimmune Therapeutics
ADAP
$669K ﹤0.01%
81,739
+46,243
+130% +$289K
CAH icon
2711
CALL
Cardinal Health
CAH
$54.9B
$669K ﹤0.01%
+10,000
New +$707K
AFAM
2712
DELISTED
Almost Family Inc
AFAM
$669K ﹤0.01%
12,451
-4,253
-25% -$217K
QEP
2713
PUT
DELISTED
QEP RESOURCES, INC.
QEP
$668K ﹤0.01%
77,900
-55,400
-42% -$453K
KPTI icon
2714
Karyopharm Therapeutics
KPTI
$43.5M
$665K ﹤0.01%
4,037
-941
-19% -$135K
SMHI icon
2715
SEACOR Marine Holdings
SMHI
$264M
$665K ﹤0.01%
42,510
+8,192
+24% +$119K
CALA
2716
DELISTED
Calithera Biosciences, Inc
CALA
$662K ﹤0.01%
2,101
+29
+1% +$9.15K
COTY icon
2717
CALL
Coty
COTY
$2.34B
$661K ﹤0.01%
40,000
– –
BEAT
2718
CALL
DELISTED
BioTelemetry, Inc.
BEAT
$660K ﹤0.01%
20,000
– –
BEAT
2719
PUT
DELISTED
BioTelemetry, Inc.
BEAT
$660K ﹤0.01%
20,000
– –
PSTB
2720
DELISTED
Park Sterling Corp.
PSTB
$659K ﹤0.01%
+53,078
New +$616K
IHG icon
2721
InterContinental Hotels
IHG
$24.2B
$658K ﹤0.01%
+11,818
New +$659K
CF icon
2722
CALL
CF Industries
CF
$19.4B
$657K ﹤0.01%
18,700
– –
PACB icon
2723
Pacific Biosciences
PACB
$466M
$657K ﹤0.01%
125,240
+102,218
+444% +$439K
STLA icon
2724
PUT
Stellantis
STLA
$19.9B
$657K ﹤0.01%
+36,700
New +$508K
AEM icon
2725
CALL
Agnico Eagle Mines
AEM
$113B
$656K ﹤0.01%
14,500
-63,400
-81% -$2.97M
107 108
109
110 111

Similar funds

Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

David Shaw's Q3 2017 Portfolio in Review

As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
  • David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
  • David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
  • David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
  • David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
  • David Shaw opened 469 new positions and closed 370 in Q3 2017.
  • David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.